Emerging biomarkers in systemic sclerosis.


PURPOSE OF REVIEW The severity of each organ involvement, natural course, and response to therapies are extremely heterogeneous among patients with systemic sclerosis (SSc). The discovery and validation of biomarkers can help identify disease risk, improve early diagnosis and prognosis, better design clinical trials and assess response to treatment, and… (More)
DOI: 10.1097/BOR.0000000000000324


2 Figures and Tables